If you’ve been reading up on the side effects of osteoporosis medications, you have undoubtedly heard about osteonecrosis of the jaw, and osteonecrosis and Fosamax in particular. In fact, some law suits are underway against the makers of Fosamax (Merck) due to this horrible side effect.
Osteocrenosis and Fosamax have an unpleasant but inescapable link. First observed in connection with the drug around 2003, osteonecrosis of the jaw is not merely a bothersome side effect. It’s really gruesome and can result in disfigurement of the jaw and face. The jaw bone begins to die and the flesh begins to decay away from the area, exposing the bone to more infection. It’s extremely difficult to treat, and may involve removing segments of the jaw itself.
How does Fosamax do this? First, let’s take a look at how osteonecrosis happens.
No Blood, No Bone
Generally speaking, osteonecrosis of the jaw (and any other bone or joint) results from an inadequate blood supply to the area. The loss of blood to the bone means that the usual remodeling can’t take place; blood carries the osteoblasts and osteoclasts to your bones and joints. Various causal factors can come into play to cut off the blood supply to a particular bone or area of bone, from illness to injury to medication.
Enter Fosamax, a bisphosphonate that is intended to increase bone density and decrease the symptoms of osteoporosis. It has a long list of side effects already, and it looks like yet another one can be added. A study conducted at the University of Washington indicated that Fosamax may cause circulatory problems, specifically atrial fibrillation (irregular heartbeat) leading to stroke.
Could it be that this affect Fosamax has on circulation could be a contributing factor to Fosamax and osteonecrosis of the jaw (ONJ)? Stroke results when circulation is cut off to the brain, usually due to a blood clot (fibrillation can result in blood clots). The upper jaw is certainly near the brain – could there be a connection? It’s worth considering.
While the fibrillation-stroke-ONJ connection has not been firmly established, the connection between Fosamax and cases of ONJ is far more solid. A University of Southern California School of Dentistry study concluded that 4% of its dental patients who were taking Fosamax developed osteonecrosis of the jaw. Before you think that 4% is no big deal, remember that premarketing trials showed that Fosamax reduces the risk of hip fracture from 2% to 1%. And they call this success!
Low Turnover Rate
Fosamax lowers the bone turnover rate by suppressing remodeling. Here is the key to the connection between Fosamax and osteonecrosis of the jaw: bone remodeling is essential to bone health, and suppressing that remodeling adversely affects the health of the bone. This artificial process may force bone density, but at what price? If an osteoporosis patient who is taking Fosamax goes in to the dentist for a tooth extraction or denture fitting, he or she will experience some trauma to the teeth and jaw area. Normally, blood flow brings healing nutrients and bone-building cells to the traumatized area, speeding healing and replacing any injured or unhealthy bone. But in patients taking Fosamax, this basic body healing system is awry. If the traumatized jaw bone cannot heal itself via remodeling, it begins to die.
It’s just not worth it to take Fosamax or any bisphosphonate, especially when there is a viable, all-natural alternative that doesn’t have horrible side effects. With the Save Our Bones program, you won’t have to worry about any negative effects to your jaw bone or any other bone. The connection between Fosamax and osteonecrosis of the jaw will be severed if you simply refuse to turn to drugs and seek natural methods of healing. Save Our Bones is absolutely effective, and you don’t have to risk anything to do it, much less such a horrific side effect.